Tomita, Y., Takeda, M., & Matsuyama, S. (2021). The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells. Antimicrobial agents and chemotherapy, 65(5), . https://doi.org/10.1128/AAC.00020-21
Chicago Style (17th ed.) CitationTomita, Yuriko, Makoto Takeda, and Shutoku Matsuyama. "The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells." Antimicrobial Agents and Chemotherapy 65, no. 5 (2021). https://doi.org/10.1128/AAC.00020-21.
MLA (9th ed.) CitationTomita, Yuriko, et al. "The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells." Antimicrobial Agents and Chemotherapy, vol. 65, no. 5, 2021, https://doi.org/10.1128/AAC.00020-21.